Health Dictionary Find a Doctor

Allergic conjunctivitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

Overview

Allergic conjunctivitis is a group of diseases affecting the ocular surface and is usually associated with type 1 hypersensitivity reactions. Two acute disorders, seasonal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis (PAC) exist, as do three chronic diseases, vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis (GPC).

Pathophysiology

Allergic conjunctivitis is the manifestation of a predominantly IgE-mediated hypersensitivity reaction[1].

Stimulated mast cells release increased amounts of tryptase, histamine, prostaglandins and leukotrienes in tears. This is the immediate response, which lasts for the initial 20-30 min.

Degranulation of mast cells activates vascular endothelial cells to express adhesion molecules such as intercellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM) and release chemokines like regulated upon activation normal T cells expressed and secreted (RANTES), monocyte chemoattractant protein (MCP), Interleukin (IL)-8, eotaxin, macrophage inflammatory protein (MIP)-1 alpha.

Triggers the recruitment of inflammatory cells in the conjunctival mucosa, which mediate the ocular late-phase reaction[2].

Pathophysiologic characteristics of special forms of allergic conjunctivitis

Antigen-MHC class II complex interacts with T-lymphocytesDifferentiation of CD4+ T-lymphocyte into memory T-lymphocyte→ Proliferates to release cytokines[6]. Th1 derived cytokines, such as IL-2, IL-3, IFN-γ, recruit macrophages. Th2 derived cytokines, such as IL-4 and IL-5, mediate the activation and chemotaxis of eosinophils[7].

References

References

  1. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). “Allergic conjunctivitis: a comprehensive review of the literature”. Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
  2. Leonardi A (2002). “The central role of conjunctival mast cells in the pathogenesis of ocular allergy”. Curr Allergy Asthma Rep. 2 (4): 325–31. doi:10.1007/s11882-002-0061-7. PMID 12044269.
  3. Leonardi A, Secchi AG (2003). “Vernal keratoconjunctivitis”. Int Ophthalmol Clin. 43 (1): 41–58. doi:10.1097/00004397-200343010-00007. PMID 12544394.
  4. Bonini S (2004). “Atopic keratoconjunctivitis”. Allergy. 59 Suppl 78: 71–3. doi:10.1111/j.1398-9995.2004.00570.x. PMID 15245362.
  5. Niederkorn JY (2008). “Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models”. Curr Opin Allergy Clin Immunol. 8 (5): 472–6. doi:10.1097/ACI.0b013e32830edbcb. PMC 2559965. PMID 18769204.
  6. Niederkorn JY, Chen PW, Mellon J, Stevens C, Mayhew E (2010). “Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses”. J Immunol. 184 (11): 6076–83. doi:10.4049/jimmunol.0902300. PMC 2910911. PMID 20410484.
  7. Mosmann TR, Coffman RL (1989). “TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties”. Annu Rev Immunol. 7: 145–73. doi:10.1146/annurev.iy.07.040189.001045. PMID 2523712.
  8. Oboki K, Ohno T, Saito H, Nakae S (2008). “Th17 and allergy”. Allergol Int. 57 (2): 121–34. doi:10.2332/allergolint.R-07-160. PMID 18427165.
  9. Donshik PC, Ehlers WH, Ballow M (2008). “Giant papillary conjunctivitis”. Immunol Allergy Clin North Am. 28 (1): 83–103, vi. doi:10.1016/j.iac.2007.11.001. PMID 18282547.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH